Form D · Other Health Care
Luma Therapeutics, Inc.
Millbrae, CA · CIK 0001697965
Offering snapshot reported Feb 15, 2017 · SEC filing
- Reported sold
- $2.05M Offering amount: $2.61M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 6, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 15, 2017 | Initial | $2,047,338 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-280746
Source: Form D, filed Feb 15, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Evan Anderson | Director, Executive |
| Matt Likens | Director |
| John Mac Mahon | Director |
| Evan Ng | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
10 Rollins Road, Suite 120
Millbrae, CA, 94030
Millbrae, CA, 94030